Views & Analysis Dr. B: Expanding the business model from COVID vaccines to a... Cyrus Massoumi, founder of Dr.
News US trials of Gilead's remdesivir begin against COVID-19 coro... The first US trial of Gilead’s unapproved antiviral remdesivir has officially begun against the novel coronavirus disease COVID-19.
News COVID-19 could disrupt supplies of cheap generics, analysts ... An extended COVID-19 coronavirus outbreak could impact on supplies of generic drugs that many health systems rely on to keep costs as low as possible, according to a new report from ratings
News Former Seagen CEO Siegall pops up at new biotech Siegall resigned from Seagen last year amid claims of domestic abuse, though was not charged.
R&D Sponsored An inside guide to unlocking clinical research in the UK An inside guide to unlocking clinical research in the UK
